Zacks Investment Research
01 Oct 2026, 17:46 UTC · 23h ago
Verdict
Headline takes no side. We score IMAX +0.90 across three claims — strongly bullish.
+0.90strongly bullish
More positive than 96% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 0 new · 3 priced in
Imax's EPS is expected to grow 29.8% this year, exceeding the industry average of 20.4%.
Priced inanalysis of projected growth
So whatBeating the industry average by nearly 1,000bps supports a valuation premium relative to the sector multiple.
More positive than 79% of claims this week
Imax is currently reporting year-over-year cash flow growth of 23.7%.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
Priced inanalysis of historical growth
So whatHigh cash accumulation reduces the probability of equity dilution via secondary offerings to fund new projects.
More positive than 66% of claims this week
The historical EPS growth rate for Imax is 50.2%.
Priced inhistorical data analysis
More positive than 44% of claims this week
Which stocks this story touches
More positive than 96% of ticker scores this week
The company is recommended as a great growth pick with a top Zacks Rank and projected EPS growth that crushes the industry average.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
2h ago
−4.8%
Price is moving against the score
$52.15 vs $54.80 close before publication (Sep 30) · not market-adjusted
IMAX chart →
